The DOI matches its Crossref record.
DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation
Abstract
Several studies have suggested that DNA hypomethylation is an early step in colorectal carcinogenesis. However, it is not clear at which stage in carcinogenesis this hypomethylation occurs, what promotes it, the extent to which it can be reversed and the consequences of such reversal in affecting tumour development. In an attempt to address some of these questions, we studied three groups of subjects with similar age and gender distributions: a group of 12 patients with colorectal carcinomas; a group of 12 patients with colorectal adenomas; and a group of eight healthy control subjects. Two experimental protocols were employed. In the first protocol, intrinsic DNA methylation was evaluated in neoplastic and in normal-appearing rectal mucosa of patients with colonic carcinomas or adenomas, compared with a group of healthy controls. In the second protocol, we examined, in a prospective and controlled fashion, the effect of folic acid supplementation (10 mg/day) on the degree of DNA methylation of rectal mucosa from those same patients after removal of the neoplasms. The degree of intrinsic DNA methylation was assessed on the basis of the capacity of the DNA isolates to serve as methyl acceptors in in vitro incubations that contained DNA methylase and [3H-methyl] S-adenosylmethionine. Intrinsic DNA methylation was significantly lower in carcinomas than in adenomas (P < 0.005). In addition, normal-appearing rectal mucosa from patients with carcinomas was significantly less methylated than in healthy controls (P < 0.005); the mean value found in the latter was also greater than the value observed in patients with adenomas, but not significantly so (P > 0.05). Patients with resected neoplasms who received folk acid supplementation for 6 months had a marked increase in the degree of intrinsic DNA methylation in the rectal mucosa (P < 0.002). Three months after cessation of treatment, DNA methylation decreased substantially (P < 0.05), but remained significantly greater than baseline values (P < 0.02). In contrast, DNA methylation values remained stable throughout the study in placebo-treated patients (P = 0.40). Our study demonstrates that global DNA hypomethylation occurs in normal rectal mucosa from patients with colorectal neoplasms as compared with controls, and that it was significantly reduced with pharmacological doses of folk add. It remains to be determined whether the risk of tumour recurrence is affected as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
Crider, K. S., Yang, T. P., Berry, R. J., & Bailey, L. B. (2012) · Advances in Nutrition · doi:10.3945/an.111.000992 · Cited by 1,015
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
Lamprecht, S. A., & Lipkin, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1144 · Cited by 583
Folate and carcinogenesis: evidence, mechanisms, and implications
Kim, Y. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(98)00074-6 · Cited by 554
Folate and colorectal cancer: An evidence‐based critical review
Kim, Y. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600191 · Cited by 419
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Metadata
- Authors
- Cravo, M., Fidalgo, P., Pereira, A. D., Gouveia-Oliveira, A., Chaves, P., Selhub, J., Mason, J. B., Mira, F. C., & Leitao, C. N.
- Venue
- European Journal of Cancer Prevention
- Published
- 1994-11
- Volume
- 3
- Issue
- 6
- Pages
- 473-480
- ISSN
- 0959-8278 (ISSN-L)
- OpenAlex
- W1990111757
- Cited by
- 169
- References
- 0
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. https://app.cochat.ai/papers/10.1097/00008469-199411000-00004
- The paper
- Cravo, M., Fidalgo, P., Pereira, A. D., Gouveia-Oliveira, A., Chaves, P., Selhub, J., Mason, J. B., Mira, F. C., & Leitao, C. N. (1994). DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. European Journal of Cancer Prevention. https://doi.org/10.1097/00008469-199411000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.